Revenue · 2011–2025
Biocryst Pharmaceuticals revenue
$875M+94.1% · FY2025
Biocryst Pharmaceuticals (BCRX) reported $875M in revenue for fiscal 2025, +94.1% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $875M | +94.1% | Open → |
| FY20242024-12-31 | $451M | +36.0% | Open → |
| FY20232023-12-31 | $331M | +22.4% | Open → |
| FY20222022-12-31 | $271M | +72.3% | Open → |
| FY20212021-12-31 | $157M | +782.4% | Open → |
| FY20202020-12-31 | $17.8M | −63.5% | Open → |
| FY20192019-12-31 | $48.8M | +136.5% | Open → |
| FY20182018-12-31 | $20.7M | −18.0% | Open → |
| FY20172017-12-31 | $25.2M | −4.4% | Open → |
| FY20162016-12-31 | $26.4M | −45.4% | Open → |
| FY20152015-12-31 | $48.3M | +254.6% | Open → |
| FY20142014-12-31 | $13.6M | −21.5% | Open → |
| FY20132013-12-31 | $17.3M | −34.1% | Open → |
| FY20122012-12-31 | $26.3M | +33.9% | Open → |
| FY20112011-12-31 | $19.6M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +31.1%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biocryst Pharmaceuticals revenue |url=https://companiesranked.com/en/company/biocryst-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biocryst Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/biocryst-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-biocryst-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Biocryst Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biocryst-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-012240 · February 26, 2026
{{cite web |title=Biocryst Pharmaceuticals revenue — 10-K (0001628280-26-012240) |url=https://www.sec.gov/Archives/edgar/data/882796/000162828026012240/bcrx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.